Tenolam AR Kit Tablet

Tenolam AR Kit tablet consists of the active substance called Atazanavir, Lamivudine, Ritonavir, Tenofovir Disoproxil Fumarate, which belongs to the class of antiretroviral or antiviral medicine. This medicine treats HIV (human immunodeficiency virus) infection. It is a nucleotide reverse transcriptase inhibitor (NRTI) and works by inhibiting the enzymes (HIV reverse transcriptase) important for virus replication. This tablet is not studied in patients over 65 years of age.

Do not consume Tenolam AR Kit tablet if you have experienced allergic reactions to Atazanavir, Lamivudine, Ritonavir, Tenofovir Disoproxil Fumarate, or any of its ingredients. During the Atazanavir, Lamivudine, Ritonavir, and Tenofovir Disoproxil Fumarate tablet treatment, your doctor may periodically monitor your blood counts, bone mineral density, heart, liver, and kidney parameters to prevent serious complications. Report to your doctor if you have had a history of heart failure  (PR prolongation), hypersensitivity (toxic skin eruptions, or Stevens-Johnson syndrome), pancreatitis, bone disease (osteonecrosis – the death of bone tissue), fractures, liver (chronic hepatitis B or C), or kidney problems.

Patients consuming this medicine may develop immune reconstitution syndrome, diabetes mellitus, excessive body fat, and hyperglycemia. Tenolam AR Kit tablet should not be given to patients with existing kidney problems. If you have lactose intolerance, notify your doctor before starting the treatment. Inform your doctor if you are planning to get pregnant or think you may be pregnant. Breastfeeding is not recommended due to the potential transmission of HIV from the mother to the baby.